pathCast Lecture | Spotlight on Innovation: Practical Advances in Rare and Orphan Hematologic Diseases

September 3, 2024

Hematologic diseases have witnessed cutting-edge innovations related to diagnosis and treatment. It is important to stay updated about recent advances. Rare hematologic diseases are often underdiagnosed or misdiagnosed.

Current trends in rare hematologic diseases are not well addressed. This adversely impacts patient care and disease outcome. Gaining knowledge on the will improve future patient management and research. 
 

Target Audience

Pathologists, pathology residents/fellows, hematologists, oncologists and researchers

Learning Objectives

  • Outline recent advances in rare hematologic diseases.
  • Discuss innovations related to underrecognized hematologic diseases.
  • Integrate and participate in multidisciplinary approach to management of rare hematologic diseases.
  • Utilize this knowledge for future research related to rare hematologic diseases.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | Spotlight on Innovation: Practical Advances in Rare and Orphan Hematologic Diseases for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
09/03/2024
Activity expires: 
09/04/2024
Event starts: 
09/03/2024 - 9:00am PDT
Event ends: 
09/03/2024 - 10:00am PDT
Add to calendar: 
City of Hope ~ Virtual Meeting
Duarte 91010

Robert S. Ohgami, MD, PhD, FCAP  Professor and Vice President of Research and Innovations; University of Utah School of Medicine

Presenter: Dr. Ohgami has indicated that there are no relevant financial relationships.

Planner: Dr. Rifat Mannan has indicated that there are no relevant financial relationships.

This presentation and/or comments will provide a balanced, non-promotional, and evidence-based approach to all diagnostic, therapeutic and/or research related content. 

CME Committee/Reviewer no relevant financial relationships:  Daneng Li, MD

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | Spotlight on Innovation: Practical Advances in Rare and Orphan Hematologic Diseases for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.